Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ping-Tee Tan"'
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-17 (2021)
Abstract Background Missing data are common in randomised controlled trials (RCTs) and can bias results if not handled appropriately. A statistically valid analysis under the primary missing-data assumptions should be conducted, followed by sensitivi
Externí odkaz:
https://doaj.org/article/592898a57c244327944675096e4bcce8
Autor:
Ping-Tee Tan, Mohamed Ismail Abdul Aziz, Fiona Pearce, Wan-Teck Lim, David Bin-Chia Wu, Kwong Ng
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Non-small-cell lung cancer (NSCLC) accounts for 85% of all lung cancers and is associated with a poor prognosis. Afatinib is an irreversible ErbB family blocker recommended in clinical guidelines as a first-line treatment for NSCL
Externí odkaz:
https://doaj.org/article/a648f17157914f9e908b6b4c5c736c8c
Publikováno v:
BMC Medical Research Methodology, Vol 21, Iss 1, Pp 1-17 (2021)
BMC Medical Research Methodology
BMC Medical Research Methodology
Background Missing data are common in randomised controlled trials (RCTs) and can bias results if not handled appropriately. A statistically valid analysis under the primary missing-data assumptions should be conducted, followed by sensitivity analys
Additional file 2: Table S1. Underlying assumptions for missing data. Table S2. Model details for trials implementing MICE (n=12). Table S3.Model details for trials implementing regression based MI (n=4). Table S4. Key characteristic of the 16 RCTs t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32e8a75339706f44a50d1627935440b9
Additional file 1 Table S1. PRISMA checklist for reporting systematic reviews.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::828b9dc2b8b1cf6269d7b444f0b5ba4b
Autor:
Ling Eng Tan, Gerald Seng Wee Chua, Mohamed Ismail Abdul Aziz, Ping-Tee Tan, Fiona Pearce, David Bin-Chia Wu, Liang Lin, Kwong Ng
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Purpose To assess the comparative efficacy of short-acting muscarinic antagonists (SAMAs), long-acting muscarinic antagonists (LAMAs), LAMA in combination with long-acting beta-agonists (LABAs; LAMA/LABAs) and inhaled corticosteroids (ICS) in combina
Publikováno v:
Value in Health. 21:S102